Stocksigma LogoStocksigma Logo

Sun Pharmaceutical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 1,61,987 (+11.9% YoY | +5.9% QoQ) ■ EBITDA: 47,439 (+4.8% YoY | +7.4% QoQ) ■ EBITDA Margin (%): 29.3 (-198 bps YoY | +41 bps QoQ) ■ PAT: 19,885

Sun Pharmaceutical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26

Sun Pharmaceutical Industries Ltd · Financial Result · 30 Oct 2026, 7:44 pm

Sun Pharmaceutical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 1,61,987 (+11.9% YoY | +5.9% QoQ) ■ EBITDA: 47,439 (+4.8% YoY | +7.4% QoQ) ■ EBITDA Margin (%): 29.3 (-198 bps YoY | +41 bps QoQ) ■ PAT: 19,885 (-36.2% YoY | -31.3% QoQ) ■ EPS (INR): 8.30 (-36.2% YoY | -31.4% QoQ)

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements